• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Unstable alpha-chain hemoglobin variants with factitious beta-thalassemia biosynthetic ratio: Hb Questembert (alpha 131[H14]Ser-->Pro) and Hb Caen (alpha 132[H15]Val-->Gly).

作者信息

Wajcman H, Vasseur C, Blouquit Y, Rosa J, Labie D, Najman A, Reman O, Leporrier M, Galacteros F

机构信息

INSERM U299, CHU de Bicêtre, France.

出版信息

Am J Hematol. 1993 Apr;42(4):367-74. doi: 10.1002/ajh.2830420407.

DOI:10.1002/ajh.2830420407
PMID:8493987
Abstract

Hb Questembert [alpha 131(H14)Ser-->Pro] was found in several members of a French family suffering from congenital Heinz body anemia. The unstable hemoglobin was expressed in the peripheral red blood cells at a very low level. Globin biosynthetic studies revealed a high specific activity of the abnormal chain and an alpha-/beta-labeling ratio similar to that of beta-thalassemia trait. Hb Caen [alpha 132(H15) Val-->Gly] is another unstable variant with the same globin biosynthesis abnormality. In both cases the structural modification is localized at the end of the H helix, a region encoded by the third exon. The mechanism for the unbalanced globin synthesis is not yet clear. It may be related 1) to a defect in chain assembly, 2) to an increased rate of degradation of the variant chain followed by the release of unlabeled beta-chains from the abnormal hemoglobin, thus leading to an apparent suppression of beta-chain synthesis, or 3) to a modified stability of the abnormal alpha-globin mRNA.

摘要

相似文献

1
Unstable alpha-chain hemoglobin variants with factitious beta-thalassemia biosynthetic ratio: Hb Questembert (alpha 131[H14]Ser-->Pro) and Hb Caen (alpha 132[H15]Val-->Gly).
Am J Hematol. 1993 Apr;42(4):367-74. doi: 10.1002/ajh.2830420407.
2
Distinct phenotypic expression associated with a new hyperunstable alpha globin variant (Hb heraklion, alpha1cd37(C2)Pro>0): comparison to other alpha-thalassemic hemoglobinopathies.与一种新的高度不稳定α珠蛋白变体(Hb 伊拉克利翁,α1cd37(C2)Pro>0)相关的独特表型表达:与其他α地中海贫血血红蛋白病的比较。
Blood Cells Mol Dis. 2000 Aug;26(4):276-84. doi: 10.1006/bcmd.2000.0307.
3
Rare thalassemic syndrome caused by interaction of Hb Questembert (alpha1 codon 131, TCT>CCT, Ser>Pro) with an alpha-thalassemia-2 deletion: implications for diagnosis and management.
Blood Cells Mol Dis. 2004 Jan-Feb;32(1):118-23. doi: 10.1016/j.bcmd.2003.10.009.
4
Modification of hemoglobin H disease by sickle trait.镰状性状对血红蛋白H病的修饰作用。
J Clin Invest. 1979 Oct;64(4):1024-32. doi: 10.1172/JCI109539.
5
Interactions of unstable hemoglobin Rush with thalassemia and hemoglobin E result in thalassemia intermedia.不稳定血红蛋白Rush与地中海贫血和血红蛋白E的相互作用导致中间型地中海贫血。
Hematology. 2019 Dec;24(1):459-466. doi: 10.1080/16078454.2019.1621020.
6
Effect of Mutations on mRNA and Globin Stability: The Cases of Hb Bernalda/Groene Hart and Hb Southern Italy.突变对 mRNA 和珠蛋白稳定性的影响:Hb Bernalda/Groene Hart 和 Hb 意大利南部的案例。
Genes (Basel). 2020 Jul 31;11(8):870. doi: 10.3390/genes11080870.
7
Post-translational control of human hemoglobin synthesis: the role of the differential affinity between globin chains in the control of mutated globin gene expression.人类血红蛋白合成的翻译后调控:珠蛋白链间差异亲和力在突变珠蛋白基因表达调控中的作用。
Biochim Biophys Acta. 1980 Dec 11;610(2):339-51. doi: 10.1016/0005-2787(80)90015-5.
8
Ten Years of Routine α- and β-Globin Gene Sequencing in UK Hemoglobinopathy Referrals Reveals 60 Novel Mutations.英国血红蛋白病转诊病例中十年常规α和β珠蛋白基因测序发现60种新突变。
Hemoglobin. 2016;40(2):75-84. doi: 10.3109/03630269.2015.1113990. Epub 2015 Dec 4.
9
Molecular genetics of human hemoglobin synthesis.人类血红蛋白合成的分子遗传学
Ann Intern Med. 1979 Oct;91(4):605-16. doi: 10.7326/0003-4819-91-4-605.
10
Dominantly Inherited beta-Thalassemia.显性遗传性β地中海贫血
Hemoglobin. 2007;31(2):193-207. doi: 10.1080/03630260701290092.